Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

FDA grades Abc Compounding's foaming mango hand wash recall as moderate-risk, nationwide and still open

A US-wide recall of a mango-scented antiseptic wash from Abc Compounding Co., Inc. has been logged under the agency's middle risk tier, with manufacturing-practice lapses cited as the cause.

04 Nov 2026 · FDA enforcement report · Regulator

The US drug regulator has added a recall of Aero Foamy Mango Aloe Vera Antiseptic Hand & Body Wash, made by Abc Compounding Co., Inc., to its weekly enforcement report dated 4 November 2026. The entry carries the number D-0087-2027 and is marked as ongoing.

The agency attributes the action to departures from current good manufacturing practice, the quality rules governing how drugs are made and controlled. Distribution is described as nationwide across the US, so the withdrawal is not confined to a single region or channel.

The classification is Class II. By the agency's own definition (offered here as context, not as a finding about this product), that tier covers products whose use or exposure may cause temporary or medically reversible harm, or where the chance of serious harm is remote. It sits below the most severe grade.

The material available to us is thin. It does not state lot numbers, units affected, distribution dates or the specific manufacturing failings, and it does not say how customers are being notified or whether any adverse events have been reported. There is also no information on the commercial scale of the product or the financial impact on the company, so any effect on revenue or supply cannot be assessed from this record.

Because the status is ongoing, the entry may be updated or closed out later. Anyone handling the product would need the full enforcement report listing for the batch details.

Why it matters

  • A manufacturing-practice deviation alone, with no reported injury in the available record, was enough to put a topical antiseptic into a nationwide recall.
  • Distributors and retailers stocking the product should consult the full FDA entry for lot and code information, which is missing from the summary.
  • The commercial cost to Abc Compounding is unknown: no volumes, values or customer-notification details are given.
  • Regulatory and quality teams can follow D-0087-2027 for any later update or termination.

Official record: FDA enforcement report ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →